These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3968834)

  • 1. Kinetic analysis of lipoproteins.
    Asmal AC
    JAMA; 1985 Feb; 253(7):978-9. PubMed ID: 3968834
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cholesterol and triglyceride content of lipoproteins in hyperlipoproteinemia type II/a, II/b and IV].
    Romics L; Karádi I; Simonyi E
    Orv Hetil; 1980 Oct; 121(43):2629-31. PubMed ID: 7208011
    [No Abstract]   [Full Text] [Related]  

  • 3. [New results of studies of plasma lipoprotein metabolism and the pathogenesis of hyperlipoproteinemias].
    Szollár L
    Orv Hetil; 1984 Oct; 125(43):2599-609. PubMed ID: 6493768
    [No Abstract]   [Full Text] [Related]  

  • 4. [Type C apoproteins in hyperlipidemia].
    Loeper J; Goy-Loeper J
    Bull Acad Natl Med; 1982 Mar; 166(3):383-9. PubMed ID: 6751485
    [No Abstract]   [Full Text] [Related]  

  • 5. [Apolipoproteins: their role in lipoprotein metabolism and the diagnostic value of their determination (literature review)].
    Titov VN; Cherniad'eva IF; Alamdarova IN; Osipov SG
    Lab Delo; 1983; (6):29-38. PubMed ID: 6193318
    [No Abstract]   [Full Text] [Related]  

  • 6. [Structural variations of VLDV triglycerides in some cases of primary observed hyperlipoproteinemias].
    Szollár L; Romics L; Pucsok J
    Orv Hetil; 1980 Jan; 121(1):11-7. PubMed ID: 7366958
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum lipoprotein lipids after gemfibrozil treatment.
    Schwandt P; Weisweiler P; Neureuther G
    Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood lipoprotein disorders in severely ill patients with threatened fat embolism].
    Blachowska B; Bobilewicz D; Wasiutyński A
    Pol Tyg Lek; 1983 Feb; 38(9):287-90. PubMed ID: 6346294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dyslipoproteinemias in rural population of the Chuvash ASSR].
    Budylina GE; Vasil'eva NP; Saperov VN
    Ross Med Zh; 1992; (1):49-50. PubMed ID: 1535253
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal effects of hypertriacylglycerolemic very low-density lipoproteins on 3-hydroxy-3-methylglutaryl-CoA reductase activity and viability of cultured bovine aortic endothelial cells.
    Gianturco SH; Eskin SG; Navarro LT; Lahart CJ; Smith LC; Gotto AM
    Biochim Biophys Acta; 1980 Apr; 618(1):143-52. PubMed ID: 7378428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Familial normolipidemic dyslipoproteinemia].
    Bicanová J; Kelbich J; Scheihauer E
    Vnitr Lek; 1981 Feb; 27(2):115-21. PubMed ID: 7467153
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment].
    László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P
    Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258
    [No Abstract]   [Full Text] [Related]  

  • 13. An approach to the management of hyperlipoproteinemia.
    Hoeg JM; Gregg RE; Brewer HB
    JAMA; 1986 Jan 24-31; 255(4):512-21. PubMed ID: 3510334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of blood lipid content and occurrence of hyperlipoproteinemias in hypertensive patients of various age.
    Tokar AV; Chayalo PP; Rudaya ES
    Z Alternsforsch; 1985; 40(1):41-6. PubMed ID: 3976251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of triglyceride rich lipoproteins with very light density by ultracentrifugation and agarose gel electrophoresis using triglyceride- and cholesterol-staining.
    Hidaka H; Tozuka M; Meyer B; Yamauchi K; Sugano M; Nakabayashi T; Katsuyama T
    Ann Clin Lab Sci; 2003; 33(2):167-78. PubMed ID: 12817621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lipid composition of blood plasma lipoproteins in primary and secondary hyperlipoproteinemias].
    Titov VN; Gerasimova EN; Shcherbakova IA; Dzhumaev DS
    Ter Arkh; 1976; 48(9):66-72. PubMed ID: 186907
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of lipid metabolic coefficient K2 in patients with hyperlipoproteinemia type IV before and after reduction of triglyceride level by adapted diet therapy].
    Drouin P; Lambert D; Mejean L; Pointel JP; Debry G
    Nutr Metab; 1979; 23(5):416-28. PubMed ID: 225702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipoproteinemia--problems of diagnosis and treatment. Report of the Working Group of the Polish Cardiology Society].
    Michajlik A; Ciświcka-Sznajderman M; Sznajd J; Szostak W
    Kardiol Pol; 1982; 25(12):1061-8. PubMed ID: 7169735
    [No Abstract]   [Full Text] [Related]  

  • 19. [Relationship between phenotype and pathophysiology of dyslipoproteinemia].
    Takeuchi N
    Rinsho Byori; 1984 Jun; 32(6):590-8. PubMed ID: 6387222
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate.
    Nye ER; Sutherland WH; Temple Wa
    N Z Med J; 1980 Nov; 92(671):345-9. PubMed ID: 6935550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.